TCL Archive IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed. April 16, 2010
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication July 22, 2011
TCL Archive The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress October 31, 1986
TCL Archive CMS Abandons Proposal To Require Further Certification Of Clinical Trials For Coverage. October 19, 2007
